Galapagos | DEBITO



Debt Cambiamento Data
AstraZeneca USD 31.65B 1.35B 2025-03
Biogen USD 6.3B 2M 2025-03
Genmab DKK 143M 886M 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
GRIFOLS EUR 10.05B 820.09M 2025-03
Hikma Pharmaceutical USD 1.28B 85M 2024-06
Incyte USD 37.12M 840K 2025-03
Merck EUR 10.27B 1.11B 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
UCB EUR 3.03B 13M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Galapagos DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.